Physician profile
Joydeep Ghosh
NPI 1578528444
$5,078.90
in general payments reported to CMS, 2019-2025
22 companies · $1,699 in 2025
The $1,699 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $547 · 2021: $976 · 2022: $706 · 2023: $137 · 2024: $416 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480 · Travel and Lodging: $732 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.34 |
| Travel and Lodging | $732.33 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,365.31 | 2019-2025 | Ingevity+, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Biosense Webster, INC. | $471.03 | 2021-2022 | |
| Cvrx, INC. | $290.74 | 2022 | |
| Medtronic, INC. | $169.99 | 2021-2025 | Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.92 | 2019 | |
| Pfizer INC. | $98.21 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.57 | 2019-2020 | |
| Vital Connect, INC | $85.04 | 2025 | Vitalpatch Rtm |
| Baylis Medical Company INC | $47.45 | 2021 | |
| Cardiva Medical, INC. | $38.78 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abbott Laboratories | $38.17 | 2025 | Ensite |
| Amgen INC. | $36.05 | 2019 | |
| Medtronic Vascular, INC. | $31.65 | 2020 | |
| Janssen Pharmaceuticals, INC | $30.74 | 2019 | |
| Atricure, INC. | $28.94 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $23.87 | 2020 | |
| Lundbeck LLC | $23.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.19 | 2019 | |
| Cordis US Corp. | $17.50 | 2025 | Mynx Control Venous |
| Astellas Pharma US INC | $16.81 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joydeep Ghosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.